Literature DB >> 17714830

Extrasynaptic GABAA receptors in the crosshairs of hormones and ethanol.

Istvan Mody1.   

Abstract

Gamma-aminobutyric acid (GABA) is the main chemical inhibitory neurotransmitter in the brain. In the central nervous system (CNS) it acts on two distinct types of receptor: an ion channel, i.e., an "ionotropic" receptor permeable to Cl- and HCO3- (GABAA receptors) and a G-protein coupled "metabotropic" receptor that is linked to various effector mechanisms (GABAB receptors). This review will summarize novel developments in the physiology and pharmacology of GABAA receptors (GABAARs), specifically those found outside synapses. The focus will be on a particular combination of GABAAR subunits sensitive to ovarian and adrenal cortical steroid hormone metabolites that are synthesized in the brain (neurosteroids) and to sobriety impairing concentrations of ethanol. These receptors may be the final common pathway for interactions between ethanol and ovarian and stress-related neurosteroids.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17714830      PMCID: PMC2291573          DOI: 10.1016/j.neuint.2007.07.010

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  50 in total

1.  Neurosteroids shift partial agonist activation of GABA(A) receptor channels from low- to high-efficacy gating patterns.

Authors:  Matt T Bianchi; Robert L Macdonald
Journal:  J Neurosci       Date:  2003-11-26       Impact factor: 6.167

2.  Neuroactive steroids reduce neuronal excitability by selectively enhancing tonic inhibition mediated by delta subunit-containing GABAA receptors.

Authors:  Brandon M Stell; Stephen G Brickley; C Y Tang; Mark Farrant; Istvan Mody
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-17       Impact factor: 11.205

3.  Segregation of different GABAA receptors to synaptic and extrasynaptic membranes of cerebellar granule cells.

Authors:  Z Nusser; W Sieghart; P Somogyi
Journal:  J Neurosci       Date:  1998-03-01       Impact factor: 6.167

4.  Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor.

Authors:  M D Majewska; N L Harrison; R D Schwartz; J L Barker; S M Paul
Journal:  Science       Date:  1986-05-23       Impact factor: 47.728

5.  Two novel GABAA receptor subunits exist in distinct neuronal subpopulations.

Authors:  B D Shivers; I Killisch; R Sprengel; H Sontheimer; M Köhler; P R Schofield; P H Seeburg
Journal:  Neuron       Date:  1989-09       Impact factor: 17.173

Review 6.  The diversity of GABAA receptors. Pharmacological and electrophysiological properties of GABAA channel subtypes.

Authors:  W Hevers; H Lüddens
Journal:  Mol Neurobiol       Date:  1998-08       Impact factor: 5.590

7.  Properties of putative cerebellar gamma-aminobutyric acid A receptor isoforms.

Authors:  N C Saxena; R L Macdonald
Journal:  Mol Pharmacol       Date:  1996-03       Impact factor: 4.436

8.  Delta subunit inhibits neurosteroid modulation of GABAA receptors.

Authors:  W J Zhu; J F Wang; K E Krueger; S Vicini
Journal:  J Neurosci       Date:  1996-11-01       Impact factor: 6.167

9.  Reported alcohol use in women with premenstrual syndrome.

Authors:  M B Tobin; P J Schmidt; D R Rubinow
Journal:  Am J Psychiatry       Date:  1994-10       Impact factor: 18.112

10.  Ethanol enhances alpha 4 beta 3 delta and alpha 6 beta 3 delta gamma-aminobutyric acid type A receptors at low concentrations known to affect humans.

Authors:  M Wallner; H J Hanchar; R W Olsen
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-18       Impact factor: 11.205

View more
  18 in total

1.  Alcohol usage and abrupt cessation modulate diurnal activity.

Authors:  Stacy Norrell; Cruz Reyes-Vasquez; Keith Burau; Nachum Dafny
Journal:  Brain Res Bull       Date:  2010-07-06       Impact factor: 4.077

2.  Unanticipated structural and functional properties of delta-subunit-containing GABAA receptors.

Authors:  Kuldeep H Kaur; Roland Baur; Erwin Sigel
Journal:  J Biol Chem       Date:  2009-01-13       Impact factor: 5.157

Review 3.  GABAA receptor-mediated tonic depolarization in developing neural circuits.

Authors:  Juu-Chin Lu; Yu-Tien Hsiao; Chung-Wei Chiang; Chih-Tien Wang
Journal:  Mol Neurobiol       Date:  2013-09-11       Impact factor: 5.590

Review 4.  Neurosteroids and GABAergic signaling in health and disease.

Authors:  Georgina MacKenzie; Jamie Maguire
Journal:  Biomol Concepts       Date:  2013-02

5.  Behavioral pharmacogenetic analysis on the role of the α4 GABA(A) receptor subunit in the ethanol-mediated impairment of hippocampus-dependent contextual learning.

Authors:  Jesse D Cushman; Melissa D Moore; Nate S Jacobs; Richard W Olsen; Michael S Fanselow
Journal:  Alcohol Clin Exp Res       Date:  2011-09-21       Impact factor: 3.455

6.  The wake-promoting transmitter histamine preferentially enhances α-4 subunit-containing GABAA receptors.

Authors:  Matt T Bianchi; Alison G Clark; Janet L Fisher
Journal:  Neuropharmacology       Date:  2011-05-27       Impact factor: 5.250

7.  Acute ethanol impairs photic and nonphotic circadian phase resetting in the Syrian hamster.

Authors:  Christina L Ruby; Rebecca A Prosser; Marc A DePaul; Randy J Roberts; J David Glass
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-12-10       Impact factor: 3.619

8.  Classification of genes and putative biomarker identification using distribution metrics on expression profiles.

Authors:  Hung-Chung Huang; Daniel Jupiter; Vincent VanBuren
Journal:  PLoS One       Date:  2010-02-04       Impact factor: 3.240

Review 9.  How adaptation of the brain to alcohol leads to dependence: a pharmacological perspective.

Authors:  Peter Clapp; Sanjiv V Bhave; Paula L Hoffman
Journal:  Alcohol Res Health       Date:  2008

10.  Long-lasting distortion of GABA signaling in MS/DB neurons after binge-like ethanol exposure during initial synaptogenesis.

Authors:  Haiying Wang; Dustin W DuBois; Angelika N Tobery; William H Griffith; Paul Brandt; Gerald D Frye
Journal:  Brain Res       Date:  2013-05-15       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.